Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.715 USD | +0.41% | -4.50% | +21.80% |
May. 14 | Atea Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 14 | Transcript : Atea Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.80% | 312M | |
+8.81% | 114B | |
+11.43% | 104B | |
-12.65% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.15% | 17.89B | |
+7.86% | 14.28B | |
+35.69% | 12.55B |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- Transcript : Atea Pharmaceuticals, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-14-2021 02